Search results
Results From The WOW.Com Content Network
At the program's height, it was in 75% of American school districts. It was funded by the federal government in the Drug-Free Schools and Communities Act of 1986, which mentions D.A.R.E. by name. [4] In 2002, D.A.R.E. had an annual budget of over $10 million. [5] A Pontiac Firebird in D.A.R.E. livery in Evesham Township, New Jersey.
DARE to Say No posits that improving the public's perception of police was at least as important to DARE's mission as keeping kids off drugs. Police departments had to carefully consider whom ...
Mountains of research show that drug education strategies of the 1980s and 90s were ineffective. Schools are hoping an updated approach will have more of an impact. D.A.R.E. didn’t work.
Reagan speaking at a "Just Say No" rally in Los Angeles, in 1987 "Just Say No" was an advertising campaign prevalent during the 1980s and early 1990s as a part of the U.S.-led war on drugs, aiming to discourage children from engaging in illegal recreational drug use by offering various ways of saying no.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
The change from the Act of 1986 to the Act of 1988 concerns the mandatory minimum penalties to drug trafficking conspiracies and attempts that previously were applicable only to substantive completed drug trafficking offenses. The Act amended 21 U.S.C. 844 to make crack cocaine the only drug with a mandatory minimum penalty for a first offense ...
Karyn Hascal, The Healing Place’s president and CEO, said she would never allow Suboxone in her treatment program because her 12-step curriculum is “a drug-free model. There’s kind of a conflict between drug-free and Suboxone.” For policymakers, denying addicts the best scientifically proven treatment carries no political cost.
Introduced in the Senate as the "Enduring Patient Access and Effective Drug Enforcement Act of 2015" by Orrin Hatch (R–UT) on February 12, 2015; Committee consideration by Senate Judiciary Committee; Passed the Senate on March 17, 2016 Passed the House on April 12, 2016 Signed into law by President Barack Obama on April 19, 2016